Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,950
datasets available to search
ShareScore release 0.9.0
Dataset results
10,950 results for “hosting”
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)
ClinicalTrials.gov study NCT02959944. IPD Sharing: YES. Countries: 15. Publications: 1.
Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids
ClinicalTrials.gov study NCT03616184. IPD Sharing: NO. Countries: 1. Publications: 1.
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
ClinicalTrials.gov study NCT03139604. IPD Sharing: NO. Countries: 19. Publications: 2.
RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT04014790. IPD Sharing: NO. Countries: 1. Publications: 1.
A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transpla
ClinicalTrials.gov study NCT02993783. IPD Sharing: YES. Countries: 5. Publications: 1.
Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)
ClinicalTrials.gov study NCT01380535. IPD Sharing: NO. Countries: 8. Publications: 1.
A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)
ClinicalTrials.gov study NCT04934670. IPD Sharing: NO. Countries: 9. Publications: 1.
Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids
ClinicalTrials.gov study NCT02379442. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
ClinicalTrials.gov study NCT01106833. IPD Sharing: YES. Countries: 1. Publications: 2.
Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant
ClinicalTrials.gov study NCT01754389. IPD Sharing: Not stated. Countries: 1. Publications: 1.
rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease
ClinicalTrials.gov study NCT02702518. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant
ClinicalTrials.gov study NCT02206035. IPD Sharing: NO. Countries: 1. Publications: 7.
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
ClinicalTrials.gov study NCT02208037. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
ClinicalTrials.gov study NCT02841995. IPD Sharing: NO. Countries: 1. Publications: 2.
Novel Experimental COVID-19 Therapies Affecting Host Response
ClinicalTrials.gov study NCT04924660. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
ClinicalTrials.gov study NCT02195869. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
ClinicalTrials.gov study NCT00755040. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease
ClinicalTrials.gov study NCT00529035. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
ClinicalTrials.gov study NCT04710576. IPD Sharing: NO. Countries: 16. Publications: 1.
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)
ClinicalTrials.gov study NCT00224874. IPD Sharing: YES. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.